1 Spors, Kelly. Computerized IRAs For Small Employers?
Vilma Lazzarini edited this page 2026-09-12 16:44:38 +08:00
This file contains ambiguous Unicode characters!

This file contains ambiguous Unicode characters that may be confused with others in your current locale. If your use case is intentional and legitimate, you can safely ignore this warning. Use the Escape button to highlight these characters.


smartcustomer.comThey could say they earn money via trading and show screenshots of profitable investments. This is perhaps arduous, but it surely continues to be essential to report the rip-off. Drain maintenance removes current blockages and construct-up. Policies usually exclude incidents tied to uncared for upkeep schedules. Your report may help stop future victims. Many victims solely notice problems after they attempt to withdraw their cash or make investments a bigger amount. As soon as contaminants circulation backwards they'll settle or congeal in department strains, creating the right storm for hidden corrosion and stubborn blockages. Success depends upon how rapidly the report is made. Most victims are embarrassed, and they would like not to discuss it. A dependable roofing contractor must be able to indicate a portfolio of completed work. Small cues hardly ever repair themselves; catching them early stops minor hygiene issues from snowballing into multi-commerce clean-ups Some victims even see small earnings at first. Slot annual inspections into your upkeep calendar and youll protect every person who turns on a faucet, avoid compliance headaches and keep these deeper, costlier drain issues from ever taking root.

SRC:MixSentence, IDs:4F45A2FE;8E020393;430C4AF5;D7418648;029700BB;3AD5669B;CEC0943E;5E804A06;2C342F27;6B520626;EA73E075;F7F7F036;167CCA31;FEE5A7E4;AF24C528;07405E10;FDCAA27E;F1FE3AF6;F4EC029B;CC2BCDF5;49E5C53D;CE505E59;A29C6F39;103B5D06;878FED22;63624C40;03D22A85
"The time it takes for a new technology to be adopted by 50 percent of US households has long been used by economic historians for cross-technology comparisons. "But, of course, inferences can be made." One such "potential theoretical conclusion" of the article, Ms. Markowitz and Kennerly S. Patrick of the Medical University of South Carolina - agreed to what Intramed and Novartis proposed. "I think we're quite clear on what you want the next manuscript to look like," Dr. Patrick said as the call concluded. "Obviously, we have to stick within data limits of what's published currently as well as what we know are factual about these products," he told the doctors. To produce the new draft, Intramed turned to Linda Logdberg, who has a doctorate in anatomy and has made her living the last 12 years as a ghostwriter for Intramed and other medical marketing companies. Zabusky added, was that a drug that worked for 9 hours might be better than a 12-hour drug. The assignment was one of her last ghostwriting tasks. Logdberg, who recently took a job teaching biology to high school students, said that she had become increasingly disenchanted with the process. Logdberg said that she produced a new manuscript in a few days. Some doctors fretted over each comma, Dr. Starting with an outline approved by Intramed, Dr. The marketing companies, she added, "will drop a doctor if they don't think he will be particularly malleable." The result, Dr. Logdberg said, while others made no changes at all. We would like to help draft this manuscript," Marcia Zabusky, a vice president of Intramed, told the doctors in a conference call, according to a transcript of the conversation obtained by The New York Times, "and then submit it to you for your - for your editing and for approval." During the call, Shane Schaffer, a Novartis marketing executive, told the doctors that the company wanted "a quick, down and dirty" article. "We make editorial suggestions," said Jed A. Typically, she said, her manuscript would be sent to the drug company for approval before it was given to the doctors who were paid to be listed as the authors. "What I mind is advertising that calls itself education." The ad agencies' medical education companies say that they neither toy with science nor ghostwrite articles that physicians use to make decisions about prescribing drugs. A study expected to provide scientific data showing Ritalin LA's advantages was not scheduled to start until the following day, he said, but the lack of research findings should not be an obstacle. "No figure, no table, anything goes in without our approval," Dr. Beitler, chairman of Sudler & Hennessey, a division at WPP that includes Intramed. Neither the doctors nor the companies disputed the accuracy of the transcript of their conference call. Logdberg said, is marketing masquerading as science. Instead, the company said, it was a review of the available medications in which the authors could suggest theoretical advantages. Patrick added that he thought, based on past research, that a drug like Ritalin LA could be better for certain children than other long-lasting drugs. Novartis said the article was not intended to conclude that one product was better than the others. "The doctors are the ultimate writers." Dr. Beitler said that Intramed was unhappy with the manuscript that Dr. Logdberg produced and later gave the assignment to another writer. The article has not been published. Evidence of ghostwriting has also surfaced in federal and state investigations of Warner-Lambert's marketing of Neurontin, an epilepsy drug, for more than a dozen unapproved uses. One document made public in a whistle-blower lawsuit against Warner-Lambert describes how Proworx, a company owned by the ad giant Omnicom, offered to help write journal articles about using Neurontin to treat pain. Patrick agreed, saying that Intramed did not dictate what their paper should say. Proworx planned to recruit doctors to be the named authors of the articles, paying them a $1,500 fee. Relman, the former editor of The New England Journal of Medicine, said there was no place in medical education for ad agencies. Wyeth hired ghostwriters in promoting the diet drug combination fen-phen, according to documents made public in litigation filed after it became evident that fen-phen caused a potentially deadly heart-valve defect. Some experts think the practice continues to grow, even as the best journals take steps to prevent it. Omnicom declined to comment on the matter. A 1998 survey of named authors writing for some of the nation's top journals, including The Journal of the American Medical Association, which published the survey, found that 11 percent of the articles had been ghostwritten. If you have any kind of questions concerning where and how you can utilize Law Firm Reviews, you could contact us at the page. "We don't get anywhere in medicine without objective data," he said. "That's the coin of the realm.